Ftse Mib
33.987,67
-0,35%
DAX
18.475,45
0,12%
S&P 500
5.567,19
1,06%
NASDAQ
18.352,76
0,90%
Bitcoin
56.517,45
-0,23%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSXV (IMV) (IMV) Notizie

IMV

(IMV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:IMV
DataOraFonteTitoloSimboloCompagnia
26/08/201420:25PR Newswire (Canada)IIROC Trading Resumption - IMVTSXV:IMV
26/08/201420:25PR Newswire (Canada)L’OCRCVM permet la reprise de la négociation - IMVTSXV:IMV
26/08/201414:16PR Newswire (Canada)IIROC Trading Halt - IMVTSXV:IMV
26/08/201414:16PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - IMVTSXV:IMV
11/06/201415:18Marketwired CanadaImmunovaccine Appoints Marc Mansour as Chief Executive OfficerTSXV:IMV
02/06/201414:05MarketwiredImmunovaccine Reports Promising Clinical Activity for Novel T Cell Activating Immunotherapy DPX-Survivac at ASCO 2014TSXV:IMV
28/05/201423:05MarketwiredImmunovaccine Announces Financial Results for Quarter Ended March 31, 2014TSXV:IMV
20/05/201414:05MarketwiredImmunovaccine's Novel Immunotherapy Triggers Partial Response & Generates Potent Immune Responses in Ovarian Cancer Clinical ...TSXV:IMV
12/05/201423:31Marketwired CanadaImmunovaccine Clarifies May 12, 2014 Trading ActivityTSXV:IMV
07/05/201416:42Marketwired CanadaImmunovaccine Announces Withdrawal of Preliminary ProspectusTSXV:IMV
06/05/201421:16Marketwired CanadaImmunovaccine Announces Overnight Marketed Equity FinancingTSXV:IMV
24/04/201414:05MarketwiredImmunovaccine Announces Results of 2014 Annual General MeetingTSXV:IMV
08/04/201414:05MarketwiredImmunovaccine's DepoVax(TM) Technology Underpins New Experimental Therapy for Cervical, Head and Neck CancersTSXV:IMV
07/04/201414:05Marketwired CanadaImmunovaccine Highlights Enhanced Anti-Tumor Activity of Cancer Vaccine Combination Therapies in Presentation at the 2014 AAC...TSXV:IMV
03/04/201414:05MarketwiredImmunovaccine to Present Data on Cancer Vaccine Combination Therapies at the 2014 AACR Annual MeetingTSXV:IMV
01/04/201414:05MarketwiredImmunovaccine and Pfenex Report Positive Results from Single Dose Anthrax Vaccine StudiesTSXV:IMV
17/03/201413:05Marketwired CanadaImmunovaccine Announces 2013 Year-End ResultsTSXV:IMV
20/01/201414:07MarketwiredLlew Keltner, US Biotech Industry Adviser, Joins Board of ImmunovaccineTSXV:IMV
20/01/201414:05MarketwiredImmunovaccine Grants Stock OptionsTSXV:IMV
09/01/201414:05MarketwiredImmunovaccine to Present at 6th Annual Biotech Showcase ConferenceTSXV:IMV
16/12/201314:05MarketwiredImmunovaccine Elects Marc Mansour, Ph.D. to Board of DirectorsTSXV:IMV
29/11/201314:05MarketwiredImmunovaccine Announces Financial Results for Quarter Ended September 30, 2013TSXV:IMV
21/11/201313:05Marketwired CanadaImmunovaccine Raises $4.2 Million in Private PlacementTSXV:IMV
28/10/201313:05Marketwired CanadaImmunovaccine Announces a Non-Brokered Private Placement of $3.2 millionTSXV:IMV
11/10/201322:54Marketwired CanadaImmunovaccine Retains B & D Capital Partners For Strategic Investor Relations ServicesTSXV:IMV
09/09/201314:17Marketwired CanadaImmunovaccine Reports Positive Results from Two Anthrax StudiesTSXV:IMV
03/09/201322:05Marketwired CanadaImmunovaccine Announces Management Team ChangesTSXV:IMV
29/08/201323:05Marketwired CanadaImmunovaccine Announces Financial Results for the Quarter Ended June 30, 2013TSXV:IMV
02/08/201315:27Marketwired CanadaImmunovaccine Secures $5 Million Loan to Support Clinical Stage Cancer Vaccines and DepoVax(TM) PlatformTSXV:IMV
15/07/201314:05Marketwired CanadaImmunovaccine and NCIC Clinical Trials Group To Collaborate on Phase II Study of DPX-SurvivacTSXV:IMV
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:IMV

La tua Cronologia

BIT
P1WRJ0
NLBNPIT1WRJ0 20991231 13...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network